SLC31A1 and non-small cell lung carcinoma: Thus, g.116002464A>G (rs7851395) and g.116004033C>A (rs12686377) cause CTR1 downregulation[148], which has been associated with a worse response of NSCLC patients to platinum derivative therapy[148].